专利号:US-11891375-B2 优先权日:2021-07-26 标 题 :Method for the synthesis of 2,4-dimethylpyrimidin-5-ol, intermediates, and method for the synthesis of Lemborexant using the intermediates 发明人:AKHATOU ABDESLAM; DOBARRO RODRÃ?GUEZ ALICIA 权利人:MOEHS IBERICA SL 摘要:A method is for the synthesis of 2,4-dimethylpyrimidin-5-ol, which can be used as an intermediate compound in the synthesis of Lemborexant. The method includes reacting a nitrophenyl compound with N,N-dimethylformamide diethyl acetal.
专利号:US-2008125587-A1 优先权日:2006-05-25 标 题 :Synthesis of triazole compounds that modulate HSP90 activity 发明人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA 权利人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA 摘要:The present invention provides novel methods of preparing triazole compounds which inhibit the activity of Hsp90. One embodiment of the invention is directed to methods for preparing a triazole compound represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising the steps of: a) reacting an amide represented by the following Structural Formula: n n n n n n n n n n with a thionation reagent to form a thioamide; b) reacting the thioamide of step a) with hydrazine to form a hydrazonamide; c) reacting the hydrazonamide of step b) with a carbonylation or a thiocarbonylation reagent. n In one embodiment, the present invention is a method of synthesis of a compound of formula (IA) n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising reacting a compound of formula (IIA) n n n n n n n n n n with an oxidizing agent, thereby producing a compound of formula (IA). n The present invention is also directed to a method of preparing a compound or a tautomer thereof represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof. The method comprises the step of reacting a first starting compound represented by the following Structural Formula: n n n n n n n n n n in the presence of a mercuric salt, with a second starting compound represented by the following Structural Formula:
专利号:US-11858901-B2 优先权日:2019-10-30 标 题:3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6 trifluoromethyl benzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione or a salt thereof, process for its preparation, and its use in the synthesis of elagolix 发明人:BALLETTE ROBERTO; JIMÉNEZ ALONSO OSCAR; GARCÃ?A GARCÃ?A ELENA; DOBARRO RODRÃ?GUEZ ALICIA 权利人:MOEHS IBERICA SL 摘要:A new intermediate is useful in the synthesis of elagolix. A process for obtaining the intermediate includes reacting a precursor with iodine monochloride in the presence of an organic solvent. A process for preparing elagolix makes use of the intermediate. The intermediate can be 3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6-trifluoromethylbenzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione or a salt thereof, such as a hydrochloride.
专利号:EP-4186890-A1 优先权日:2021-11-29 标题 :Preparation of n-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide for the synthesis of tirbanibulin 发明人:ARE CELESTE; BALLETTE ROBERTO; DOBARRO RODRÃ?GUEZ ALICIA 权利人:MOEHS IBERICA SL 摘要:The present invention relates to a process for the preparation of N-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide, which is a suitable intermediate for the synthesis of tirbanibulin or a pharmaceutically acceptable salt thereof, as well as to a process for the preparation of tirbanibulin or a pharmaceutically acceptable salt thereof using said N-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide intermediate.
专利号:US-12024731-B2 优先权日:2017-05-03 标 题 :Methods and enzyme catalysts for the synthesis of non-canonical amino acids 发明人:BOVILLE CHRISTINA E; BRINKMANN-CHEN SABINE; BULLER ANDREW R; ROMNEY DAVID K; PRIER CHRISTOPHER K; KOCH PHILIPP; SCHEELE REMKES A 权利人:CALIFORNIA INST OF TECHN 摘要:The present disclosure provides methods for preparing β-substituted tryptophan compounds. The methods include: combining i) an unsubstituted indole or a substituted indole, ii) a β-substituted serine, and iii) a tryptophan synthase β-subunit (i.e., a TrpB); and maintaining the resulting mixture under conditions sufficient to form the β-substituted tryptophan. The TrpB contains at least one amino acid mutation which promotes formation of an amino-acrylate intermediate. New TrpB variants and new β-substituted tryptophan analogs are also described.
专利号:US-2018222848-A1 优先权日:2015-08-04 标 题:Salt of Dihydrophenylglycine Methyl Ester 发明人:VAN DER DOES THOMAS; MOODY HAROLD MONRO; LI WEIDONG 权利人:DSM SINOCHEM PHARM NL BV 摘要:The present invention relates to the hemi sulfuric acid salt of methyl (R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetate, also trivially referred to as the hemi sulfuric acid salt of D-dihydrophenylglycine methyl ester, to a method for the preparation of said salt and to the use of said salt in the enzymatic synthesis of antibiotics.
1: Sin DW, Wong YL, Cheng EC, Lo MF, Ho C, Mok CS, Wong SK. S1 certification of alpha-endosulfan, beta-endosulfan, and endosulfan sulfate in a candidate certified reference material (organochlorine pesticides in tea) by isotope dilution gas chromatography-mass spectrometry. Anal Bioanal Chem. 2015 Apr;407(11):3009-21. doi: 10.1007/s00216-015-8455-2. Epub 2015 Jan 27. doi: 10.1080/09593330.2014.937464. Epub 2014 Jul 21. doi: 10.1021/es504837z. Epub 2015 Feb 4. doi: 10.1016/j.ecoenv.2014.02.025. Epub 2014 Mar 28. doi: 10.1016/j.scitotenv.2014.01.050. Epub 2014 Jan 31. doi: 10.1007/s00253-013-4774-4. Epub 2013 Mar 7. Review. doi: 10.1016/j.envpol.2015.08.023. Epub 2015 Aug 28. doi: 10.1021/jf404404w. Epub 2014 Feb 21. doi: 10.1016/j.scitotenv.2014.03.016. Epub 2014 Apr 1. doi: 10.1007/s12010-015-1504-7. Epub 2015 Feb 1. doi: 10.1016/j.scitotenv.2013.08.070. Epub 2013 Sep 19. doi: 10.3109/10520295.2014.936507. Epub 2014 Aug 25. doi: 10.1007/s00253-013-5033-4. Epub 2013 Jun 29. doi: 10.1080/03601234.2015.975596. doi: 10.1007/s00244-015-0164-5. Epub 2015 May 21. doi: 10.1016/j.jhazmat.2014.05.073. Epub 2014 Jun 2. doi: 10.1016/j.chemosphere.2014.10.046. Epub 2014 Nov 18. doi: 10.1016/j.mce.2014.11.028. Epub 2014 Dec 5. doi: 10.1002/bio.2892. Epub 2015 Mar 24.
合成参考文献
参考文献:10.1007/s11356-011-0561-x 摘要:Turgut C, Atatanir L, Mazmanci B, Mazmanci MA, Henkelmann B, Schramm K. The occurrence and environmental effect of persistent organic pollutants (POPs) in Taurus Mountains soils. Environmental Science and Pollution Research. 2011 Jul 13;19(2):325–34. doi: 10.1007/s11356-011-0561-x. 参考文献:10.1007/s10661-011-2167-7 摘要:Anjum R, Malik A. Mutagenicity assessment of contaminated soil in the vicinity of industrial area. Environmental Monitoring and Assessment. 2011 Jul 15;184(5):3013–26. doi: 10.1007/s10661-011-2167-7. 参考文献:10.1007/s00128-011-0353-5 摘要:Cantu-Soto EU, Meza-Montenegro MM, Valenzuela-Quintanar AI, Félix-Fuentes A, Grajeda-Cota P, Balderas-Cortes JJ, Osorio-Rosas CL, Acuña-García G, Aguilar-Apodaca MG. Residues of Organochlorine Pesticides in Soils from the Southern Sonora, Mexico. Bulletin of Environmental Contamination and Toxicology. 2011 Jul 15;87(5):556. doi: 10.1007/s00128-011-0353-5. 参考文献:10.1073/pnas.1105209108 摘要:Ren A, Qiu X, Jin L, Ma J, Li Z, Zhang L, Zhu H, Finnell RH, Zhu T. Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proc Natl Acad Sci U S A. 2011 Aug 02;108(31):12770–5.